| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 01/15/2009 | US20090018085 Use of a GnRH antagonist peptide in the treatment of sex hormone-dependent diseases |
| 01/15/2009 | US20090018053 Formulations for amylin agonist peptides |
| 01/15/2009 | US20090017502 Interferon-alpha polypeptides and conjugates |
| 01/15/2009 | US20090017501 Interferon-alpha polypeptides and conjugates |
| 01/15/2009 | US20090017500 Covalently attached to a nonpeptide moiety; nucleic acids encoding the polypeptides; reducing the number of copies of a virus in infected cells; administering antiviral polypeptide |
| 01/15/2009 | US20090017473 Compositions and methods for the diagnosis and treatment of tumor |
| 01/15/2009 | US20090017121 dispersed in a polymerc matrix comprising swellable hydrophilic polyethylene oxide that swells unrestrained dimensionally by imbibing H2O to increase its size to promote gastric retention of the dosage form in a stomach in fed mode, upon contact with H2O gabapentin released by diffusion; bioavailability |
| 01/15/2009 | US20090017119 Modifications of solid 3-sn-phosphoglycerides |
| 01/15/2009 | US20090017117 Pellet formulation for the treatment of the intestinal tract |
| 01/15/2009 | US20090017106 Adjuvants on the basis of bisacyloxypropylcystene conjugates and derivatives and their uses in pharmaceutical compositions |
| 01/15/2009 | US20090017099 Cholesterol-rich composite food that is rendered substantially non-cholesterolemic using phytosterols |
| 01/15/2009 | US20090017094 Method Of Fabricating A Tissue Engineering Scaffold |
| 01/15/2009 | US20090017090 Devices and methods for delivering active agents to the osteomeatal complex |
| 01/15/2009 | US20090017084 skin-friendly formulations comprising permethrin and agonists or antagonists of nicotinic acetylcholine receptors of insects, in particular imidacloprid, for controlling parasitic insects on animals |
| 01/15/2009 | US20090017075 Immunomodulatory compositions, methods of making, and methods of use thereof |
| 01/15/2009 | US20090017047 Preparation for the Prevention and Treatment of Stress Conditions as Well as Functional and Organic Disorders of the Nervous System and Metabolic Disorders |
| 01/15/2009 | US20090016985 Polymeric drug delivery system containing a multi-substituted aromatic moiety |
| 01/15/2009 | US20090016969 Pharmaceutical composition for topical application of poorly soluble compounds |
| 01/15/2009 | CA2693742A1 Molecules for targeting compounds to various selected organs, tissues or tumor cells |
| 01/15/2009 | CA2693061A1 Compositions for topical application for the treatment of keratinization disorders |
| 01/15/2009 | CA2693048A1 Molecules for targeting compounds to various selected organs or tissues |
| 01/15/2009 | CA2692698A1 Preserving secondary peptide structure |
| 01/15/2009 | CA2692610A1 Pharmaceutical preparations containing highly volatile silicones |
| 01/15/2009 | CA2692482A1 Pharmaceutical composition for topical application of poorly soluble compounds |
| 01/15/2009 | CA2691695A1 Glp-1-fc fusion protein formulation |
| 01/15/2009 | CA2691398A1 Dermatological composition containing calcitriol lipidic vesicles, method for preparing same and use thereof |
| 01/15/2009 | CA2690773A1 Pharmaceutical liquid composition of botulinum toxin with improved stability |
| 01/14/2009 | EP2014308A2 A coating employing an anti-thrombotic conjugate |
| 01/14/2009 | EP2014307A2 Micellar drug delivery vehicles and uses thereof |
| 01/14/2009 | EP2014306A2 Metal-polysaccharide conjugates: compositions and synthesis |
| 01/14/2009 | EP2014305A1 Sprayable gel-type skin/mucosa-adhesive preparation and administration system using the preparation |
| 01/14/2009 | EP2014304A1 Colon cleansing compositions |
| 01/14/2009 | EP2014298A2 Interleukin-22 polypeptides, nucleic acids encoding the same and methods for the treatment of pancreatic disorders |
| 01/14/2009 | EP2014289A1 Pharmaceutical composition for intracellular acidification with cis-urocanid acid |
| 01/14/2009 | EP2014286A2 Cremophor free epothilone particles coated with protein for treating cancer |
| 01/14/2009 | EP2014180A1 Composition useful for the reduction of the cardivascular risk and foods that contain it |
| 01/14/2009 | EP2013016A2 Liposomal nanoparticles and other formulations of fenretinide for use in therapy and drug delivery |
| 01/14/2009 | EP2012937A2 Systems and methods for producing multilayered particles, fibers and sprays and methods for administering the same |
| 01/14/2009 | EP2012872A2 Treating cancer using electromagnetic fields in combination with other treatment regimens |
| 01/14/2009 | EP2012831A2 Nanogel contrast agents for optical molecular imaging |
| 01/14/2009 | EP2012821A2 Antibodies for the detection of bacillus anthracis and vaccine against b. anthracis infections |
| 01/14/2009 | EP2012788A2 Pre-mixed, ready-to-use iv bolus compositions and methods of use |
| 01/14/2009 | EP2012767A2 Formulations containing amide derivatives of carboxylic acid nsaids for topical administration to the eye |
| 01/14/2009 | EP2012765A2 Compositions and methods useful for treatment of respiratory illness |
| 01/14/2009 | EP2012751A2 Novel nanoparticles for delivery of active agents |
| 01/14/2009 | EP2012705A2 Pharmaceutical formulations for iontophoretic drug delivery |
| 01/14/2009 | EP1592402A4 Dispersion of taste masked crystals or granules of active substances, chewable soft capsules filled with said dispersion, and process for preparing same |
| 01/14/2009 | EP1588707B1 Stable solid medicinal composition for oral administration of ramosetron |
| 01/14/2009 | EP1456386B1 Polycistronic expression of antibodies in cho cells |
| 01/14/2009 | EP1429915B1 Systems, methods and apparatuses for manufacturing dosage forms |
| 01/14/2009 | EP1429769B1 New formulations and use thereof |
| 01/14/2009 | EP1406678B1 Drug delivery matrices to enhance wound healing |
| 01/14/2009 | EP1348428B1 Powdery preparations and process for producing the same |
| 01/14/2009 | EP1311241B1 Use of a porous carrier |
| 01/14/2009 | EP1297142B1 Dual specificity antibodies and methods of making and using |
| 01/14/2009 | EP1245636B1 Composition for hydrogel, hydrogel, and use thereof |
| 01/14/2009 | EP1223978B1 Archaeosomes as adjuvants and carriers for acellular vaccines to induce cytotoxic t lymphocyte (ctl) responses |
| 01/14/2009 | EP1183049B1 Modification of biological elements |
| 01/14/2009 | EP1146913B1 Conjugates of granulocyte colony stimulating factors for targeting and imaging infection and inflammation |
| 01/14/2009 | EP1107775B2 Composition containing pyrrolizidine-alkaloid-free petasites |
| 01/14/2009 | EP1068332B1 Recombinant anti-tumor rnase |
| 01/14/2009 | EP1051189B2 Vaccine formulation containing a polycation as an adjuvant and sugar-alcohols and low concentrations of anorganic ions |
| 01/14/2009 | CN101346397A Agents that bind a target in pulmonary tissue for treating respiratory diseases |
| 01/14/2009 | CN101346393A Modified siRNA molecules and uses thereof |
| 01/14/2009 | CN101346154A Water-soluble films comprising low-viscosity alginates |
| 01/14/2009 | CN101346149A Ultrasonic cancer treatment enhancer and cell killer |
| 01/14/2009 | CN101346138A Use of DHA, EPA or DHA-derived EPA for treating a pathology associated with cellular oxidative damage |
| 01/14/2009 | CN101346128A Formulation comprising a drug of low water solubility and method of use thereof |
| 01/14/2009 | CN101344648A Medicine-carrying contact lens and preparation method thereof |
| 01/14/2009 | CN101343624A Recombined human growth hormone gene bacilliform virus, preparation and application thereof |
| 01/14/2009 | CN101343421A Preparation method for pH controlled releasedynamic polymer packaging system |
| 01/14/2009 | CN101343369A Dialdehyde starch crosslinked chitosan magnetic microsphere and preparation thereof |
| 01/14/2009 | CN101343338A Emulsion polymerization technique suitable for medicament clothing sheet material polyacrylic resin II industrial production |
| 01/14/2009 | CN101342370A Instant jelly glue of carbomer for eyes |
| 01/14/2009 | CN101342369A Safety environment-friendly type medicinal propellant |
| 01/14/2009 | CN101342367A Edwardsiella tarda attenuated live vaccine |
| 01/14/2009 | CN101342346A Drop pill for treating stenocardia caused by coronary disease |
| 01/14/2009 | CN101342337A Novel trauma plaster |
| 01/14/2009 | CN101342336A Externally used anti-inflammation relieve itching soothing oil liquid medicine formulation and orally taken traditional Chinese medicine product capsule |
| 01/14/2009 | CN101342335A Externally used traditional Chinese medicine gelling agent and preparation method thereof |
| 01/14/2009 | CN101342265A Instant jelly glue of musk deer bead for eyes |
| 01/14/2009 | CN101342264A Speckle removing liquid |
| 01/14/2009 | CN101342262A Gelling agent for treating skin pruritus |
| 01/14/2009 | CN101342256A Medicament for treating hyperpiesis, cardiac disease and preparation method thereof |
| 01/14/2009 | CN101342242A Instant jelly glue of double coptis for eyes |
| 01/14/2009 | CN101342200A Patrinai villosa tablet and preparation method |
| 01/14/2009 | CN101342194A Traditional Chinese medicine preparation for treating median or late-stage malignant tumors, chronic hepatitis B, and preparation method thereof |
| 01/14/2009 | CN101342182A Instant gel rubber of physostigmine salicylate for eyes |
| 01/14/2009 | CN101342179A Antineoplastic traditional Chinese medicine preparation and preparation method thereof |
| 01/14/2009 | CN101342178A Instant gel rubber of latanoprost for eyes |
| 01/14/2009 | CN101342176A Instant gel rubber of timolol maleate for eyes |
| 01/14/2009 | CN101342172A Instant gel rubber of pilocarpine nitrate for eyes |
| 01/14/2009 | CN101342171A Instant gel rubber of clonidine hydrochloric for eyes |
| 01/14/2009 | CN101342165A Instant gel rubber of thyroxine liothyronine for eyes |
| 01/14/2009 | CN101342164A Bezafibrate controlled release formulation and preparation method thereof |
| 01/14/2009 | CN101342163A Instant gel rubber of levobunolol hcl for eyes |
| 01/14/2009 | CN101342156A Gernebcin inhalation dust cloud agent |
| 01/14/2009 | CN101342154A Preparation of internal plasticization type cellulose ethyl ether (EC) medicament sustained and controlled release aqueous clothing sheet agent |
| 01/14/2009 | CN101342153A Risperidone osmotic pump controlled release tablets and preparation method thereof |
| 01/14/2009 | CN101342152A Butylbenzene phthalein tablet and preparation method thereof |